FDA Should Nix Drug Risk Proposal, Advocacy Group Says
By Sindhu Sundar ( October 23, 2014, 6:44 PM EDT) -- Consumer advocacy group Public Citizen argued Wednesday that the U.S. Food and Drug Administration should revoke a proposal that the group said would allow pharmaceutical companies to downplay the risks of medications that are indicated on their FDA-approved labels. ...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.